Radiation Oncology/Therapy

Siemens to invest €70 million to expand site in Germany
By AuntMinnieEurope.com staff writers
The hall will have a total floor area of about 4,500 square meters, including 3,400 square meters of production space for radiotherapy components.
July 15, 2026
Siemens2
Actineer completes Ra-226 recycling process to support Ac-225 supply
By AuntMinnie.com staff writers
This process aims to improve Ac-225 supply predictability and cost stability, as well as reduce waste generation.
July 14, 2026
Nuclear Medicine Worker Sm
Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial
By AuntMinnie.com staff writers
The study is evaluating an investigational alpha-emitting PSMA-targeted radiopharmaceutical in prostate cancer patients.
July 9, 2026
Blue Earth Therapeutics Logo
Single-fraction SBRT a valid option for localized prostate cancer
By Will Morton
Estimated three-year biochemical relapse-free survival was 92.9%.
June 18, 2026
Prostate Imaging
ASTRO, ESTRO to collaborate on radiation oncology clinical guidelines
By AuntMinnie.com staff writers
The agreement sets a joint committee that will oversee topic selection and guideline development.
May 18, 2026
Am 2018 10 21 20 23 4419 Astro 20181022040021
Varian's AI contouring for Eclipse treatment planning receives CE mark
By AuntMinnieEurope.com staff writers
Integrated software to be highlighted at ESTRO 2026.
May 15, 2026
Siemens Healthineers Press Ai Contouring
DOSIsoft showcases ThinkQA 3.0 at ESTRO
By AuntMinnieEurope.com staff writers
ThinkQA 3.0 is a patient-specific quality assurance platform for adaptive radiation therapy.
May 11, 2026
Rad Onc
Will upright radiotherapy become a new standard?
By Will Morton
Multiple commercial upright systems have entered the market in recent years.
May 4, 2026
Rt Upright
How best to characterize CT lung findings after radiation therapy
By Kate Madden Yee
Serial chest CT is cornerstone of post-RT surveillance, but "accurate interpretation is critical to avoid misdiagnosis."
April 17, 2026
Acute radiation-induced pneumonitis after SBRT (65 Gy, four fractions) in a 53-year-old woman with leiomyosarcoma of the uterus with a left lower lobe metastasis manifesting as a small nodule (not shown). (A) Axial dosimetric reconstruction of a CT image obtained for SBRT planning shows the metastasis receiving the maximal isodose (6500 cGy). (B) Axial CT image obtained 12 months after completion of RT shows focal ground-glass and consolidative opacities confined to the treatment plan (arrow). Note that acute lung injury with SBRT typically manifests later than with conventional RT (i.e., >12 weeks after completion of therapy), and in 25% of patients, the first CT manifestations occur more than one year after completion of RT.
Tailoring breast radiotherapy to women's risk leads to success
By Amerigo Allegretto
Many women don't have breast cancer recurrence after receiving radiotherapy following initial treatment, a study showed at EBCC15.
March 24, 2026
Radiotherapy 400
Modern EBRT reduces CVD risk in breast cancer patients
By Amerigo Allegretto
Modern EBRT for breast cancer treatment leads to minimal increases in CVD risk, an improvement over previous EBRT techniques.
April 1, 2026
Radiation Treatment Cancer Social
ECR: New guidelines point to MRI for rectal cancer evaluation
By Liz Carey
Radiologists may see increased follow-up MRI with the new 2026 rectal cancer guidelines, according to an ECR 2026 session.
March 7, 2026
Ecr Thumbnail
Page 1 of 128
Next Page